Synthesis and Evaluation of Radiogallium-Labeled Peptide Probes for In Vivo Imaging of Legumain Activity
Molecules · 2025
DOI: 10.3390/molecules30234527 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Takeshi Fuchigami und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Analytical Sciences, Graduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Ishikawa, Japa…. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Cysteine Endopeptidases, Peptides, Radiopharmaceuticals. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency, Takeda Science Foundation.
Abstract (Originalsprache)
Legumain (LGMN), a lysosomal cysteine protease, is crucial for tumor progression, invasion, and metastasis, making it a promising target for cancer imaging and therapy. This study developed novel 67Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA)-conjugated LGMN-cleavable peptide probes ([67Ga]Ga-NOTA-LCPs) composed of polyarginine and polyglutamic acid sequences linked by LGMN-cleavable sites for nuclear medicine imaging of LGMN activity. The probes were synthesized via fluorenylmethoxycarbonyl solid-phase peptide synthesis and radiolabeled in high radiochemical yields. In vitro assays with HCT116 cells showed significantly higher uptake of [67Ga]Ga-NOTA-LCPs compared to non-cleavable controls, confirming efficient cleavage and cellular uptake. In vivo studies in tumor-bearing mice revealed rapid renal clearance, low non-specific binding, and favorable tumor-to-blood ratios, particularly for [67Ga]Ga-NOTA-LCP-1. These results demonstrate the potential of [67Ga]Ga-NOTA-LCPs as effective LGMN-responsive imaging agents, with further optimization needed to improve tumor specificity and reduce off-target accumulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Clinical Analytical Sciences, Graduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Ishikawa, Japan.
- Department of Hygienic Chemistry, Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8521, Nagasaki, Japan.
- Faculty of Environmental Engineering, The University of Kitakyushu, Kitakyushu 802-8577, Fukuoka, Japan.
ORCID-Profile: Takeshi Fuchigami, Sakura Yoshida, Masayuki Munekane, Kazuma Ogawa
Förderung
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
- Takeda Science Foundation
- Kobayashi Foundation for Cancer Research
- Terumo life science foundation
- NOVARTIS Foundation for the Promotion of Science (Japan)
- Shibuya Science Culture and Sports foundation
- Hitachi Global Foundation
Zitieren
APA
Fuchigami, T., Itagaki, K., Yoshida, S., Nakayama, M., Munekane, M., & Ogawa, K. (2025). Synthesis and Evaluation of Radiogallium-Labeled Peptide Probes for In Vivo Imaging of Legumain Activity. Molecules. https://doi.org/10.3390/molecules30234527
Vancouver
Fuchigami T, Itagaki K, Yoshida S, Nakayama M, Munekane M, Ogawa K. Synthesis and Evaluation of Radiogallium-Labeled Peptide Probes for In Vivo Imaging of Legumain Activity. Molecules. 2025. doi:10.3390/molecules30234527
BibTeX
@article{Fuchigami2025,
author = {Fuchigami, Takeshi and Itagaki, Kohnosuke and Yoshida, Sakura and Nakayama, Morio and Munekane, Masayuki and Ogawa, Kazuma},
title = {Synthesis and Evaluation of Radiogallium-Labeled Peptide Probes for In Vivo Imaging of Legumain Activity},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30234527}
}
EUVIMED